Literature DB >> 9563881

Analysis of colorectal cancer by comparative genomic hybridization: evidence for induction of the metastatic phenotype by loss of tumor suppressor genes.

A Paredes-Zaglul1, J J Kang, Y P Essig, W Mao, R Irby, M Wloch, T J Yeatman.   

Abstract

Current models suggest that colon cancer initiation and progression are secondary to both the activation of oncogenes and the deletion of tumor suppressor genes. The role of each, however, is still poorly understood, particularly with regard to the induction of metastasis. We hypothesized that genetic differences exist between tumors that metastasize distantly and those that do not, and that oncogenes and tumor suppressor genes participate equally in this process. To address this hypothesis, human tumor specimens from localized [tumor-node-metastasis (TNM) stage I-III] and primary colon cancers (n = 10) were directly compared with metastatic (TNM stage IV) lesions (n = 10) using comparative genomic hybridization analysis. Although several alterations were shared equally between primary tumors and metastases (+7q, +19q, and +20q), two patterns of distinguishing alterations were observed: (a) alterations that were more extensive in liver metastases than in primary tumors (+8q, +13q, -4p, -8p, -15q, -17p, -18q, -21q, and -22q); and (b) alterations that were unique to metastatic lesions (-9q, -11q, and -17q). Overall, genetic losses were more common than gains, and, more importantly, the number of losses/tumor was significantly higher for metastases than for primary tumors (9.3 + 1.3 versus 4.1 + 0.7; P = 0.00062, Wilcoxon's rank-sum test). The distinct predominance of genetic losses in the metastatic lesions when compared with the primary localized tumors provides evidence that the metastatic phenotype is induced by the deletion of tumor suppressor genes and permits the construction of physical maps targeting regions where novel tumor suppressor genes are likely to exist.

Entities:  

Mesh:

Year:  1998        PMID: 9563881

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  15 in total

1.  Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid.

Authors:  K Birkenkamp-Demtroder; S H Olesen; F B Sørensen; S Laurberg; P Laiho; L A Aaltonen; T F Orntoft
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

2.  Chromosome 20q Amplification Defines a Subtype of Microsatellite Stable, Left-Sided Colon Cancers with Wild-type RAS/RAF and Better Overall Survival.

Authors:  Ryan N Ptashkin; Carlos Pagan; Rona Yaeger; Sumit Middha; Jinru Shia; Kevin P O'Rourke; Michael F Berger; Lu Wang; Robert Cimera; Jiajing Wang; David S Klimstra; Leonard Saltz; Marc Ladanyi; Ahmet Zehir; Jaclyn F Hechtman
Journal:  Mol Cancer Res       Date:  2017-02-09       Impact factor: 5.852

3.  Analysis of allelic imbalance in patients with colorectal cancer according to stage and presence of synchronous liver metastases.

Authors:  J C Weber; A Schneider; S Rohr; H Nakano; P Bachellier; A Méchine; G Hamel; M Kanor; M P Chenard; M P Gaub; P Oudet; C Meyer; D Jaeck
Journal:  Ann Surg       Date:  2001-12       Impact factor: 12.969

4.  Cytogenetic analyses of secondary liver tumors reveal significant differences in genomic imbalances between primary and metastatic colon carcinomas.

Authors:  L A Parada; A Marañon; M Hallén; K G Tranberg; U Stenram; G Bardi; B Johansson
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

5.  Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer.

Authors:  Greg M Arndt; Lesley Dossey; Lara M Cullen; Angela Lai; Riki Druker; Michael Eisbacher; Chunyan Zhang; Nham Tran; Hongtao Fan; Kathy Retzlaff; Anton Bittner; Mitch Raponi
Journal:  BMC Cancer       Date:  2009-10-20       Impact factor: 4.430

6.  Mapping of genetic abnormalities of primary tumours from metastatic CRC by high-resolution SNP arrays.

Authors:  José María Sayagués; Celia Fontanillo; María del Mar Abad; María González-González; María Eugenia Sarasquete; Maria del Carmen Chillon; Eva Garcia; Oscar Bengoechea; Emilio Fonseca; Marcos Gonzalez-Diaz; Javier De las Rivas; Luís Muñoz-Bellvis; Alberto Orfao
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

7.  Molecular changes in the Ki-ras and APC genes in primary colorectal carcinoma and synchronous metastases compared with the findings in accompanying adenomas.

Authors:  P Zauber; M Sabbath-Solitare; S P Marotta; D T Bishop
Journal:  Mol Pathol       Date:  2003-06

8.  Genome-wide search for loss of heterozygosity in Chinese patients with sporadic colorectal cancer.

Authors:  Zhihai Peng; Fang Zhang; Chongzhi Zhou; Yun Ling; Shaochun Bai; Wanqing Liu; Guoqiang Qiu; Lin He; Liwei Wang; Daoyan Wei; Edward Lin; Keping Xie
Journal:  Int J Gastrointest Cancer       Date:  2003

9.  Spectral karyotyping suggests additional subsets of colorectal cancers characterized by pattern of chromosome rearrangement.

Authors:  W M Abdel-Rahman; K Katsura; W Rens; P A Gorman; D Sheer; D Bicknell; W F Bodmer; M J Arends; A H Wyllie; P A Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

10.  Prognostic Impact of del(17p) and del(22q) as assessed by interphase FISH in sporadic colorectal carcinomas.

Authors:  María González-González; Luís Muñoz-Bellvis; Carlos Mackintosh; Celia Fontanillo; M Laura Gutiérrez; M Mar Abad; Oscar Bengoechea; Cristina Teodosio; Emilio Fonseca; Manuel Fuentes; Javier De Las Rivas; Alberto Orfao; José María Sayagués
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.